000 | 01983 a2200565 4500 | ||
---|---|---|---|
005 | 20250518095534.0 | ||
264 | 0 | _c20210910 | |
008 | 202109s 0 0 eng d | ||
022 | _a2095-3941 | ||
024 | 7 |
_a10.20892/j.issn.2095-3941.2019.0153 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeblanc, Olivia | |
245 | 0 | 0 |
_aBiomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma. _h[electronic resource] |
260 |
_bCancer biology & medicine _c02 2020 |
||
300 |
_a208-217 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aCetuximab _xpharmacology |
650 | 0 | 4 |
_aClass I Phosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGain of Function Mutation |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProgression-Free Survival |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
650 | 0 | 4 |
_aSquamous Cell Carcinoma of Head and Neck _xdrug therapy |
700 | 1 | _aVacher, Sophie | |
700 | 1 | _aLecerf, Charlotte | |
700 | 1 | _aJeannot, Emmanuelle | |
700 | 1 | _aKlijanienko, Jerzy | |
700 | 1 | _aBerger, Frédérique | |
700 | 1 | _aHoffmann, Caroline | |
700 | 1 | _aCalugaru, Valentin | |
700 | 1 | _aBadois, Nathalie | |
700 | 1 | _aChilles, Anne | |
700 | 1 | _aLesnik, Maria | |
700 | 1 | _aKrhili, Samar | |
700 | 1 | _aBieche, Ivan | |
700 | 1 | _aLe Tourneau, Christophe | |
700 | 1 | _aKamal, Maud | |
773 | 0 |
_tCancer biology & medicine _gvol. 17 _gno. 1 _gp. 208-217 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.20892/j.issn.2095-3941.2019.0153 _zAvailable from publisher's website |
999 |
_c30863516 _d30863516 |